Asthma drug under review
![](https://www.lundylaw.com/wp-content/themes/lundylaw/assets/img/sep-dark.png)
July 16, 2009
The Associated Press reports, the Food and Drug Administration is investigating results from a study that indicate the asthma drug Xolair can cause heart attacks, strokes, and other potentially fatal side effects.
Read More